Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Obagi - C

&times

Overview

What is Obagi - C?

Hydroquinone is 1,4 - bensenediol. Hydroquinone occurs as fine, white needles. The drug is freely

soluble in water and in alcohol. Chemically, hydroquinone is designated as p - dihydroxybenzene;

the empirical formula is C6H6O2; molecular weight is 110.11 g / moL.



What does Obagi - C look like?



What are the available doses of Obagi - C?

Sorry No records found.

What should I talk to my health care provider before I take Obagi - C?

Sorry No records found

How should I use Obagi - C?

The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles,

senile lentigines, and other unwanted areas of melanin hyperpigmentation.

A thin application should be applied once or twice daily or as directed by a physician.  no

improvement is seen after three (3) months of treatment, use of this product should be

discontinued. Sun exposure may be limited by using a sunscreen agent, a sunblocking agent,

or protective clothing to cover bleached skin when using and after using this product in order to

prevent darkening from reoccuring.


What interacts with Obagi - C?

Sorry No Records found


What are the warnings of Obagi - C?

Sorry No Records found


What are the precautions of Obagi - C?

Sorry No Records found


What are the side effects of Obagi - C?

Sorry No records found


What should I look out for while using Obagi - C?

People with prior history of sensitivity or allergic reaction to this product or any of its

ingredients should not use it. The safety of topical hydroquinone use during pregnancy

or in children (12 years and under) has not been established.

Hydroquinoone is a skin - bleaching agent, which may produce unwanted cosmetic effects if not

used as directed. The physician should be familiar with the contents of this insert before prescribing

or dispensing this product.

Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin

and check within 24 hours. Minor redness is not a contraindication, but where there is itching

or vesicle formation or excessive inflammatory response, product should be discontinued and

physician consulted. Close patient supervision is recommended.

Avoid contact with eyes, nose, mouth, and lips. In case of accidental contact, patient should

rinse thoroughly with water and contact a physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight

exposure sustains melanocytic activity.

The Obagi - C Rx Therapy Night Cream contains sodium metabisulfite, a sulfite that

may cause allergic - type reactions including anaphylactic symptoms and life - threatening or

less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite

sensitivity in the general populationis unknown and probably low. Sulfite sensitivity is seen

more frequently in asthmatic than in nonasthmatic people.


What might happen if I take too much Obagi - C?

Sorry No Records found


How should I store and handle Obagi - C?

Sorry No Records found


&times

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Topical application of hydroquinone produces a reversible depigmentation of the skin by

inhibition of the enzymatic oxidation of 3, 4 - dihydroxyphenylalanine (DOPA) and

suppression of other melanocyte metabolic processes. Exposure to sunlight or ultraviolet light

will cause repigmentation of the bleached areas, which may be prevented by the use of

sunblocking agents or sunscreen agents contained in the Obagi - C Rx System sun Shield Matte

Broad Spectrum SPF 50.

Non-Clinical Toxicology
People with prior history of sensitivity or allergic reaction to this product or any of its

ingredients should not use it. The safety of topical hydroquinone use during pregnancy

or in children (12 years and under) has not been established.

Hydroquinoone is a skin - bleaching agent, which may produce unwanted cosmetic effects if not

used as directed. The physician should be familiar with the contents of this insert before prescribing

or dispensing this product.

Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin

and check within 24 hours. Minor redness is not a contraindication, but where there is itching

or vesicle formation or excessive inflammatory response, product should be discontinued and

physician consulted. Close patient supervision is recommended.

Avoid contact with eyes, nose, mouth, and lips. In case of accidental contact, patient should

rinse thoroughly with water and contact a physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight

exposure sustains melanocytic activity.

The Obagi - C Rx Therapy Night Cream contains sodium metabisulfite, a sulfite that

may cause allergic - type reactions including anaphylactic symptoms and life - threatening or

less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite

sensitivity in the general populationis unknown and probably low. Sulfite sensitivity is seen

more frequently in asthmatic than in nonasthmatic people.

(also see WARNINGS)

Treatment should be limited to relatively small areas of the body at one time since some

patients experience a transient skin reddening and a mild burning sensation, which does not

preclude treatment.

Pregnancy Category C

Animal reproduction studies have not been conducted with topical hydroquinone. It is also

not known whether hydroquinone can case fetal harm when used topically on a pregnant woman

or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is

absorbed systemically. Topical hydroquinone should be used on pregnant women only when

clearly indicated.

Nursing Mothers

It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is

advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage

Safety and effectiveness in children below the age of 12 years have not been established.

No systemic adverse reactions have been reported. Occasional hypersensitivity (localized

contact dermatitis) may occur, in which case the product should be discontinued and physician

notified immediately.

&times

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

&times

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
&times

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
&times

Tips

Tips

&times

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).